Bayer Head Admits COVID-19 Vaccine Is Gene Therapy

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

First published on September 23, 2022

***

Stefan Oelrich, head of Bayer’s pharmaceuticals department, admitted at the World Health Summit that the COVID-19 vaccine is gene therapy. He smugly stated that the drug companies knew people would reject the vaccine if they knew it was in fact a gene-altering injectable. They lied to us for profits as the vaccine certainly did not prevent anyone from contracting or transmitting the virus.

“If we had surveyed two years ago if people were willing to take gene or cell therapy and inject it into your body we would have probably had a 95% refusal rate,” Oelrich admits while forgetting many took the “gene therapy” through force.

Twitter has already flagged retweets of this video as “misleading.” The conspiracy theorists who were told they had no place in society were right as Big Pharma and governments worldwide used the public as guinea pigs for the largest gene therapy study in history. We still do not know the long-term health implications but have seen a variety of health issues and lingering side effects in the short-term. Revolutions have occurred over much less.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.

Featured image is from Children’s Health Defense


Articles by: Martin Armstrong

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]